Limited Immunogenicity of Human Induced Pluripotent Stem Cell-Derived Cartilages-Reference-Cited by-同舟云学术

Limited Immunogenicity of Human Induced Pluripotent Stem Cell-Derived Cartilages

Published:2016-12 Issue:23-24 Volume:22 Page:1367-1375
ISSN:1937-3341
Container-title:Tissue Engineering Part A
language:en
Short-container-title:Tissue Engineering Part A

Author:

Kimura Takeshi¹²,Yamashita Akihiro¹,Ozono Keiichi²,Tsumaki Noriyuki¹

Affiliation:

1. Cell Induction and Regulation Field, Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.

2. Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.

Publisher

Mary Ann Liebert Inc

Subject

Biomedical Engineering,Biomaterials,Biochemistry,Bioengineering

Link

https://www.liebertpub.com/doi/pdf/10.1089/ten.tea.2016.0189

Reference18 articles.

1. HOMOTRANSPLANTATION OF ARTICULAR CARTILAGE AND ISOLATED CHONDROCYTES

2. Immune evasion by neocartilage-derived chondrocytes: Implications for biologic repair of joint articular cartilage

3. Cartilage immunoprivilege depends on donor source and lesion location

4. ISTO Technologies Aims to Rescue Damaged Joints

5. Clinical, Radiographic, and Histological Outcomes After Cartilage Repair With Particulated Juvenile Articular Cartilage

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. iPSCs chondrogenic differentiation for personalized regenerative medicine: a literature review;Stem Cell Research & Therapy;2024-06-26

2. Past, present, and future of cell replacement therapy for parkinson’s disease: a novel emphasis on host immune responses;Cell Research;2024-05-22

3. Dysregulation of Immune Tolerance to Autologous iPSCs and Their Differentiated Derivatives;Biochemistry (Moscow);2024-05

4. Application of hydrogel scaffolds as a cell substrate for cartilage tissue regeneration;Genes & Cells;2024-03-28

5. In vitro assessment of immunogenicity in chondrocytes obtained from the B2M knockout induced pluripotent stem cells;Medicine of Extreme Situations;2024-02